These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Liu J; Liu Y; Xia H; Zou J; Weaver SC; Swanson KA; Cai H; Cutler M; Cooper D; Muik A; Jansen KU; Sahin U; Xie X; Dormitzer PR; Shi PY Nature; 2021 Aug; 596(7871):273-275. PubMed ID: 34111888 [TBL] [Abstract][Full Text] [Related]
54. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History. Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S Front Immunol; 2021; 12():793191. PubMed ID: 34975897 [TBL] [Abstract][Full Text] [Related]
55. Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals. Ye ZW; Ong CP; Tang K; Fan Y; Luo C; Zhou R; Luo P; Cheng Y; Gray VS; Wang P; Chu H; Chan JF; To KK; Chen H; Chen Z; Yuen KY; Ling GS; Yuan S; Jin DY Cell Mol Immunol; 2022 May; 19(5):588-601. PubMed ID: 35352010 [TBL] [Abstract][Full Text] [Related]
56. Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus. Amanat F; Strohmeier S; Meade PS; Dambrauskas N; Mühlemann B; Smith DJ; Vigdorovich V; Sather DN; Coughlan L; Krammer F PLoS Biol; 2021 Dec; 19(12):e3001384. PubMed ID: 34914685 [TBL] [Abstract][Full Text] [Related]
57. The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity. Tejedor Vaquero S; de Campos-Mata L; Ramada JM; Díaz P; Navarro-Barriuso J; Ribas-Llaurado C; Rodrigo Melero N; Carolis C; Cerutti A; Gimeno R; Magri G Front Immunol; 2021; 12():737083. PubMed ID: 34539673 [TBL] [Abstract][Full Text] [Related]
58. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection. Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551 [TBL] [Abstract][Full Text] [Related]
59. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]